Inactive Instrument

News Viskase Companies, Inc. OTC Markets

Stocks

VKSC

US92831R2013

Non-Paper Containers & Packaging

All News

08-03	Viskase Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-04	Viskase Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-01	Viskase Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-30	Viskase Companies, Inc. Auditor Raises 'Going Concern' Doubt	CI
04-21	Viskase Companies, LLC Amends Credit Agreement and Extends Maturity Date	CI
04-16	Enzon Pharmaceuticals, Inc has Changed its Name to Viskase Holdings, Inc	CI
04-15	Viskase Holdings, Inc. Announces Chief Financial Officer Changes, Effective on April 10, 2026	CI
04-15	Viskase Holdings, Inc. Appoints Joseph D. King as Executive Vice President ,Effective on April 10, 2026	CI
03-26	Viskase Holdings, Inc. Announces Departure of Richard L. Feinstein as Chief Financial Officer, Effective March 26, 2026	CI
03-26	Viskase Holdings, Inc. Announces CEO Changes, Effective March 26, 2026	CI
03-26	Viskase Holdings, Inc. Announces Board and Committee Changes Following Merger, Effective March 26, 2026	CI
03-25	Viskase Companies, Inc. completed the acquisition of Enzon Pharmaceuticals, Inc. from a group of shareholders for $7.8 million in a reverse merger transaction.	CI
03-25	Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
03-24	Enzon Announces Reverse Stock Split	GL
03-19	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
03-16	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
03-11	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
03-09	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
03-02	Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-27	Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock	GL
01-30	Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger	GL
11-12	Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-24	Enzon and Viskase announce amendment to merger agreement	RE
25-10-24	Enzon and Viskase Announce Amendment to Merger Agreement	GL
25-08-14	Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI